skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Molecular basis for substrate recognition and drug resistance from 1.1 to 1.6 Å resolution crystal structures of HIV-1 protease mutants with substrate analogs

Journal Article · · FEBS J.

Research Organization:
Argonne National Laboratory (ANL), Argonne, IL (United States). Advanced Photon Source (APS)
Sponsoring Organization:
OTHER U.S. STATESNIHOTHER
OSTI ID:
1170422
Journal Information:
FEBS J., Vol. 272, Issue (20) ; 10, 2005
Country of Publication:
United States
Language:
ENGLISH

References (40)

HIV-1 protease specificity of peptide cleavage is sufficient for processing of gag and pol polyproteins journal October 1988
Retroviral Proteinases book January 1990
Structure-Based Inhibitors of HIV-1 Protease journal January 1993
Multiple Concurrent Reverse Transcriptase and Protease Mutations and Multidrug Resistance of HIV-1 Isolates from Heavily Treated Patients journal June 1998
Genotypic Testing for Human Immunodeficiency Virus Type 1 Drug Resistance journal April 2002
Mutation Patterns and Structural Correlates in Human Immunodeficiency Virus Type 1 Protease following Different Protease Inhibitor Treatments journal April 2003
Substrate Shape Determines Specificity of Recognition for HIV-1 Protease journal March 2002
Viability of a Drug-Resistant Human Immunodeficiency Virus Type 1 Protease Variant: Structural Insights for Better Antiviral Therapy journal January 2003
Structural Basis for Coevolution of a Human Immunodeficiency Virus Type 1 Nucleocapsid-p1 Cleavage Site with a V82A Drug-Resistant Mutation in Viral Protease journal October 2004
Crystallographic Analysis of Human Immunodeficiency Virus 1 Protease with an Analog of the Conserved CA-p2 Substrate. Interactions with Frequently Occurring Glutamic Acid Residue at P2' Position of Substrates journal October 1997
Structural implications of drug-resistant mutants of HIV-1 protease: High-resolution crystal structures of the mutant protease/substrate analogue complexes journal January 2001
Combining mutations in HIV-1 protease to understand mechanisms of resistance journal May 2002
Kinetics and mechanism of autoprocessing of human immunodeficiency virus type 1 protease from an analog of the Gag-Pol polyprotein. journal August 1994
HIV Type 1 Protease Cleavage Site Mutations and Viral Fitness: Implications for Drug Susceptibility Phenotyping Assays journal August 2000
Drug resistance during indinavir therapy is caused by mutations in the protease gene and in its Gag substrate cleavage sites. journal January 1997
Natural Variation in HIV-1 Protease, Gag p7 and p6, and Protease Cleavage Sites within Gag/Pol Polyproteins: Amino Acid Substitutions in the Absence of Protease Inhibitors in Mothers and Children Infected by Human Immunodeficiency Virus Type 1 journal May 1996
Polymorphism of HIV Type 1 Gag p7/p1 and p1/p6 Cleavage Sites: Clinical Significance and Implications for Resistance to Protease Inhibitors journal September 2000
Effect of sequence polymorphism and drug resistance on two HIV-1 Gag processing sites: Studies on mutant HIV-1 processing sites journal August 2002
Comparison of the HIV-1 and HIV-2 proteinases using oligopeptide substrates representing cleavage sites in Gag and Gag-Pol polyproteins journal April 1991
Substrate analog inhibition and active site titration of purified recombinant HIV-1 protease journal January 1990
Resistance to HIV Protease Inhibitors:  A Comparison of Enzyme Inhibition and Antiviral Potency journal June 1998
High Resolution Crystal Structures of HIV-1 Protease with a Potent Non-peptide Inhibitor (UIC-94017) Active Against Multi-drug-resistant Clinical Strains journal April 2004
Domain Flexibility in Retroviral Proteases:  Structural Implications for Drug Resistant Mutations , journal February 1998
Flap opening and dimer-interface flexibility in the free and inhibitor-bound HIV protease, and their implications for function journal September 1999
Drug resistance in HIV-1 protease: Flexibility-assisted mechanism of compensatory mutations journal October 2002
HIV-1 protease molecular dynamics of a wild-type and of the V82F/I84V mutant: Possible contributions to drug resistance and a potential new target site for drugs journal April 2004
NMR Evidence for the Displacement of a Conserved Interior Water Molecule in HIV Protease by a Non-Peptide Cyclic Urea-Based Inhibitor journal February 1994
Solution NMR Evidence That the HIV-1 Protease Catalytic Aspartyl Groups Have Different Ionization States in the Complex Formed with the Asymmetric Drug KNI-272 journal January 1996
Structural basis of drug resistance for the V82A mutant of HIV-1 proteinase journal March 1995
Role of Conformational Fluctuations in the Enzymatic Reaction of HIV-1 Protease journal May 2002
Crystal structures of HIV protease V82A and L90M mutants reveal changes in the indinavir-binding site journal April 2004
Selectivity in the Inhibition of HIV and FIV Protease: Inhibitory and Mechanistic Studies of Pyrrolidine-Containing .alpha.-Keto Amide and Hydroxyethylamine Core Structures journal December 1995
Inhibition and catalytic mechanism of HIV-1 aspartic protease journal January 1996
Influence of Flanking Sequences on the Dimer Stability of Human Immunodeficiency Virus Type 1 Protease journal January 1996
Chemical synthesis and expression of the HIV-1 protease gene in E.coli journal February 1989
[20] Processing of X-ray diffraction data collected in oscillation mode book January 1997
AMoRe : an automated package for molecular replacement journal March 1994
[16] SHELXL: High-resolution refinement book January 1997
Improved methods for building protein models in electron density maps and the location of errors in these models journal March 1991
MOLSCRIPT: a program to produce both detailed and schematic plots of protein structures journal October 1991